BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• BioCapital

  Osiris Therapeutics, Inc. Release: Grafix® Featured in Multiple Abstracts at the 2013 Fall Symposium on Advanced Wound Care

  September 26, 2013

   · 

  1 min read
• Drug Development

  Pharmaceutical Company Dompe Launches REP0112, a Trial to Assess the Efficacy and Safety of Reparixin in Autologous Islet Cell Transplantation

  September 26, 2013

   · 

  1 min read
• BioMidwest

  Nora Therapeutics Release: Houston Fertility Institute Participates in the Thrive-IVF Research Study to Help Improve Pregnancy Success Rates and Outcomes in Women With a History of Repeated in Vitro Fertilization (IVF) Failures

  September 26, 2013

   · 

  3 min read
• Pharm Country

  TONIX Pharmaceuticals, Inc. Release: Combatting the Enemy Many Veterans Bring Home: Post-Traumatic Stress Disorder

  September 26, 2013

   · 

  2 min read
• Pharm Country

  Olympus Launches DIEGO® ELITE Multidebrider® Platform for Sinus, Turbinate, Tonsil, Adenoid and Laryngeal Surgeries

  September 26, 2013

   · 

  4 min read
• BioMidwest

  Arteriocyte, Inc. Awarded BARDA Contract Valued up to $101.1 Million for Advanced Development of Arteriocyte’s Magellan® BioBandage™ for Thermal Radiation Injury

  September 26, 2013

   · 

  3 min read
• Drug Development

  Celladon Corporation Announces Publication of Long Term Follow-Up Results From the MYDICAR CUPID 1 Trial in Advanced Heart Failure

  September 26, 2013

   · 

  4 min read
• Drug Development

  Cerulean Pharma Inc. Release: Combinability of CRLX101 and Avastin® Established in Clinical Trial in Renal Cell Carcinoma

  September 26, 2013

   · 

  4 min read
• GE Healthcare Release: New Data Show Benefit of DaTSCAN™ (Ioflupane I 123 Injection) in the Diagnosis of Patients With Clinically Uncertain Dementia With Lewy Bodies

  September 26, 2013

   · 

  1 min read
• Drug Development

  John Theurer Cancer Center Announces Positive Results From Revlimid MCL-001(EMERGE) Study Leading to FDA Approval of First Oral Therapy for Refractory Mantle-Cell Lymphoma (MCL) Patients

  September 26, 2013

   · 

  4 min read